Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
A3P Biomedical AB (publ)
AB
Active
Org 5592529100
Kungsgatan 24, 111 35
Stockholm
Activities of head offices
·
NACE 7010
Est. 2020 · 6 years old
32 employees
Monitor
Share
Sweden
/
Companies
/
Activities of head offices
/
A3P Biomedical AB (publ)
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
24M
18M
12M
6M
0M
2021: 19M
19M
2021
2022: 5M (-74% vs 2021)
5M
-74%
2022
2023: 3M (-40% vs 2022)
3M
-40%
2023
2024: 3M (0% vs 2023)
3M
0%
2024
2025: 0M (-100% vs 2024)
0M
-100%
2025
EBITDA
SEK millions
0M
-26M
-52M
-78M
-103M
2021: -24M
-24M
2021
2022: -59M (-146% vs 2021)
-59M
-146%
2022
2023: -83M (-41% vs 2022)
-83M
-41%
2023
2024: -76M (+8% vs 2023)
-76M
+8%
2024
2025: 0M (+100% vs 2024)
0M
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
3
2 968
3 436
4 621
18 950
Staff expenses
−23
—
—
—
—
EBITDA
−83
−75 812
−82 693
−59 487
−23 912
Depreciation & amort.
−0
—
—
—
—
EBIT
−83
−75 812
−82 693
−59 487
−23 912
Net financials
0
8 632
9 447
2 590
614
Profit before tax
−79
−70 680
−82 246
−64 897
−41 798
Tax
−0
−0
−0
−0
−0
Net profit
−79
−70 680
−82 246
−64 897
−41 798
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
185
253 173
329 531
396 680
87 665
Equity
164
235 663
305 559
387 207
76 524
Long-term debt
1
427
103
0
0
Short-term debt
19
17 083
23 869
9 473
11 141
Total debt
20
17 510
23 972
9 473
11 141
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2021
2025
Equity ratio
89,1 %
This company
38,2 %
Market median
This company
Market median
133% above market
2021
2025
Return on equity
−48,0 %
This company
18,4 %
Market median
This company
Market median
361% below market
2021
2025
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2021
2025
Asset turnover
0,02×
This company
1,12×
Market median
This company
Market median
98% below market
2021
2025
Debt / equity
0,12×
This company
0,62×
Market median
This company
Market median
81% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on A3P Biomedical AB (publ)
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
